Pineapple Express Cannabis (PNXP) Cost of Revenue (2019 - 2020)
Pineapple Express Cannabis' (PNXP) quarterly Cost of Revenue came in at $5585.0 in Q4 2020, down 28.17% year-on-year from $7775.0 in Q4 2019, and down 28.17% quarter-over-quarter from $7775.0 in Q4 2019.
Pineapple Express Cannabis (PNXP) Cost of Revenue (2019 - 2020) Analysis & Trends
Pineapple Express Cannabis has disclosed Cost of Revenue across 2 years of filings, most recently posting $5585.0 for Q4 2020.
- Cost of Revenue for Q4 2020 came in at $5585.0, down 28.17% year-over-year; the trailing twelve-month figure through Jan 2022 was $5585.0 (changed 0.0% YoY), and the FY2021 annual result was $5610.0, down 27.85% from the prior year.
- Cost of Revenue came in at $5585.0 for Q4 2020 at Pineapple Express Cannabis, down from $7775.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $7775.0 in Q4 2019 to a low of $5585.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2020 | 5,585.00 |
| Oct 31, 2020 | 5,585.00 |
| Oct 31, 2019 | 7,775.00 |
| Oct 31, 2019 | 7,775.00 |